| Listed site | cdmo | both |
|---|
| Summary | Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities. | Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years. |
|---|
| Services | - Technology Transfer
- Process Development
- Cell-Line Development
- CMC Analytical Development
- Formulation Development
- Quality Control Testing
- Sterile Fill-Finish & Aseptic Manufacturing
- CMC Regulatory Submission Support
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Upstream Processing
- Downstream Processing
- Cell Therapy Manufacturing
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- mRNA Manufacturing
- Biologics Development & Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
| - CMC Regulatory Submission Support
- Quality Control Testing
- Technology Transfer
- Formulation Development
- Process Development
- Cell Therapy Manufacturing
- Viral Vector Manufacturing
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Biologics Development & Manufacturing
- API Synthesis & Manufacturing
- Upstream Processing
- Downstream Processing
- CMC Analytical Development
- Stability Testing & Storage
- Cell-Line Development
- Microbial Fermentation
- Small Molecule Development & Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
|
|---|
| Modalities | - Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- mRNA
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform
| - Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform
|
|---|
| Indications | Data not yet provided. | - Oncology
- Immunology
- Neurology
|
|---|
| Locations | - Headquarters, Seattle, Washington, USA
- Copenhagen, Copenhagen, Denmark
- Heidelberg, Heidelberg, Germany
- Milan, Milan, Italy
- Chiba, Chiba, Japan
- Yokohama, Yokohama, Japan
| - Headquarters, United States
- North America, North America, USA/Canada
- Europe, Europe, Multiple
- Asia, Asia, Multiple
- North America, North America
- Europe, Europe
- Asia, Asia
|
|---|
| Certifications | Data not yet provided. | - FDA · Identifier: 100 IND submissions containing Retrogenix® platform data
- EMA · Identifier: 100 IND submissions containing Retrogenix® platform data
- PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data
- EMA · Identifier: Retrogenix® platform data support
- PMDA · Identifier: Retrogenix® platform data support
|
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|